does bridging therapy affect lymphoma car-t outcomes?
Published 4 years ago • 156 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
4:00
the influence of bridging therapy on outcomes in large b-cell lymphoma
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
1:17
the impact of car-t therapy in the second-line setting in lymphoma
-
2:11
the role of car-t therapy for lymphoma in 2024: expert session highlights
-
1:41
advances in cellular therapies for lymphoma: the value of car-t therapy & optimizing patient outcome
-
2:53
understanding how patients relapse from car t-cell therapy
-
7:38
bernadette’s last hope for beating cancer: will car-t cell therapy cure her non-hodgkin's lymphoma?
-
15:44
panel discussion on immune therapies for lymphoma - car t-cell therapy and the question of cure
-
2:25
the future of car-t for the treatment of lymphoma
-
3:32
improving car-t therapy for all & lymphoma: allogeneic products & reducing crs/icans
-
2:57
novel targeted therapies for the treatment of bpdcn
-
1:28
car-t cell therapy debate: the future of lymphoma treatment?
-
1:48
novel immunotherapy approaches in lymphoma: car-t cells, bispecifics & sequencing
-
10:21
advances in car-t therapy for lymphoma
-
1:29
cd5.car t-cell therapy in patients with t-cell lymphoma
-
2:08
the future of car t-cell therapy in lymphoma
-
3:01
phase 1 trial of car t-cell therapy for lymphoma
-
1:38
predicting response to car-t therapy in lymphoma: challenges and strategies
-
2:29
emerging lymphoma therapies: bispecific antibodies and car t-cells
-
8:50
an update of car t-cell therapies in lymphoma
-
3:41
novel prognosis score for survival in patients with aggressive lymphoma treated with car-t therapy
-
3:04
car t-cell therapy for b-cell lymphomas: a focus on improving cr